Condition
Fecal Calprotetin clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Fecal Calprotetin clinical trials that are recruiting, in China. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Fecal Biomarker Response to Biologics in Ulcerative Colitis
This study tests whether early changes in fecal calprotectin and FIT after starting vedolizumab or infliximab can predict later response and healing in adults with moderate-to-severe ulcerative colitis.
-
Early biomarker changes after standard UC therapy predict relapse in biologic-naive patients
This study tests whether a >50% drop or normalization in qFIT and fecal calprotectin within 2 weeks of starting conventional UC therapy can predict relapse or need for biologic/JAK therapy within a year in biologic-naive patients.
Related topics
Quick answers
How many Fecal Calprotetin clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.